<p>Definitive Healthcare（纳斯达克代码：DH - 获取免费报告）在周四更新了 2026 年第二季度的收益指引。该公司提供的每股收益（EPS）指引为 0.030-0.040，而市场共识预期为 0.030。该公司发布的收入指引为 5500 万美元至 5600 万美元，而市场共识收入预期为 5570 万美元。Definitive Healthcare 还将其 2026 财年的指引更新为 0.160-0.19 EPS。</p>
<p>获取 <strong>Definitive Healthcare</strong> 的提醒：</p>
<h2>Definitive Healthcare 股价表现</h2>
<p>周四，Definitive Healthcare 的股票下跌了 0.02 美元，报 0.92 美元。该公司的交易量为 331,909 股，而其平均交易量为 354,274 股。该公司的市值为 9723 万美元，市盈率为-0.74，市盈率增长比率为 84.12，贝塔系数为 1.34。Definitive Healthcare 的一年最低价为 0.90 美元，一年最高价为 4.70 美元。该公司的债务与股本比率为 0.41，速动比率为 1.64，流动比率为 1.64。该公司的 50 日移动平均价格为 1.10 美元，200 日移动平均价格为 1.99 美元。</p>
<p>Definitive Healthcare（纳斯达克代码：DH - 获取免费报告）最近在 5 月 7 日发布了季度财报。该公司报告的每股收益（EPS）为 0.06 美元，超出分析师的共识预期 0.03 美元。Definitive Healthcare 的股本回报率为 2.63%，净利润率为-57.52%。该公司季度收入为 5593 万美元，而市场共识预期为 5502 万美元。Definitive Healthcare 将其 2026 年第二季度的指引设定为 0.030-0.040 EPS，2026 财年的指引设定为 0.160-0.19 EPS。整体来看，卖方分析师预计 Definitive Healthcare 在当前财年将发布 0.01 美元的每股收益。</p>
<h2>分析师评级升级与降级</h2>
<p>DH 成为多家研究分析师报告的主题。Canaccord Genuity Group 在 2 月 27 日的研究报告中将 Definitive Healthcare 的目标股价从 4.00 美元下调至 3.00 美元，并对该股票给予 “持有” 评级。巴克莱在 3 月 30 日的研究报告中将 Definitive Healthcare 的目标股价从 2.75 美元下调至 1.00 美元，并对该公司给予 “减持” 评级。华尔街 Zen 在 3 月 14 日的研究报告中将 Definitive Healthcare 的评级从 “持有” 上调至 “买入”。Weiss Ratings 在 1 月 21 日的研究报告中重新发布了 Definitive Healthcare 的 “卖出（d-）” 评级。最后，Zacks Research 在 4 月 28 日的研究报告中将 Definitive Healthcare 的评级从 “强烈卖出” 上调至 “持有”。一位投资分析师给予该股票 “强烈买入” 评级，一位给予 “买入” 评级，五位给予 “持有” 评级，三位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “持有”，平均目标股价为 3.27 美元。</p>
<p><strong>查看我们关于 Definitive Healthcare 的最新报告</strong></p>
<h2>机构资金流入与流出</h2>
<p>几家机构投资者和对冲基金最近调整了对 DH 的持股。高盛集团在第一季度将其在 Definitive Healthcare 的持股增加了 564.2%。高盛集团目前拥有 8716725 股该公司的股票，价值 25191000 美元，此前在此期间又购买了 7404363 股。Dimensional Fund Advisors LP 在第三季度将其在 Definitive Healthcare 的持股增加了 1.6%。Dimensional Fund Advisors LP 目前拥有 2073197 股该公司的股票，价值 8417000 美元，此前在此期间又购买了 33612 股。Arrowstreet Capital Limited Partnership 在第三季度将其在 Definitive Healthcare 的持股增加了 11.7%。Arrowstreet Capital Limited Partnership 目前拥有 1216007 股该公司的股票，价值 4937000 美元，此前在上个季度又收购了 127055 股。美国银行在第二季度将其在 Definitive Healthcare 的持股增加了 23.7%。美国银行目前拥有 769397 股该公司的股票，价值 3001000 美元，此前在此期间又收购了 147599 股。最后，Inspire Investing LLC 在第四季度将其在 Definitive Healthcare 的持股增加了 505.7%。Inspire Investing LLC 目前拥有 698967 股该公司的股票，价值 2006000 美元，此前在上个季度又收购了 583562 股。机构投资者和对冲基金持有该公司 98.67% 的股票。</p>
<h2>关于 Definitive Healthcare</h2>
<p>（获取免费报告）</p>
<p>Definitive Healthcare（纳斯达克代码：DH）是医疗服务提供者、组织及治疗患者的专业人员的情报和分析的领先提供商。通过其基于云的平台，该公司从多个来源汇总数据，包括索赔、政府登记、商业备案和专有研究，以提供医疗保健领域的统一视图。其解决方案使生命科学公司、医疗服务提供者、支付方和咨询公司能够识别市场机会，优化销售和营销工作，提高运营效率，并支持更好的患者结果。</p>
<p>该公司的旗舰产品是一个基于订阅的数据平台，提供关于医生、医院、健康系统和后期护理设施的详细资料。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票比 Definitive Healthcare 更具投资价值</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Definitive Healthcare 吗？</h2>
<p>在你考虑 Definitive Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Definitive Healthcare 并不在名单上。</p>
<p>虽然 Definitive Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Definitive Healthcare（纳斯达克代码：DH）更新了其 2026 年第二季度的盈利指引，预计每股收益（EPS）为 0.030-0.040，略高于市场共识预期的 0.030。收入指引设定在 5500 万至 5600 万美元之间，低于市场共识的 5570 万美元。该公司还修订了 2026 财年的每股收益指引至 0.160-0.19。尽管最近股价下跌至 0.92 美元，分析师们仍维持 “持有” 的共识评级，平均目标价为 3.27 美元。机构投资者持有该公司 98.67% 的股份，显示出强劲的机构支持</p>

<p>Definitive Healthcare (NASDAQ:DH - Get Free Report) updated its second quarter 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.030-0.040 for the period, compared to the consensus estimate of 0.030. The company issued revenue guidance of $55.0 million-$56.0 million, compared to the consensus revenue estimate of $55.7 million. Definitive Healthcare also updated its FY 2026 guidance to 0.160-0.19 EPS.</p>
<div class="lb-trans"><p>Definitive Healthcare（纳斯达克代码：DH - 获取免费报告）在周四更新了 2026 年第二季度的收益指引。该公司提供的每股收益（EPS）指引为 0.030-0.040，而市场共识预期为 0.030。该公司发布的收入指引为 5500 万美元至 5600 万美元，而市场共识收入预期为 5570 万美元。Definitive Healthcare 还将其 2026 财年的指引更新为 0.160-0.19 EPS。</p>
</div><p>Get <strong>Definitive Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Definitive Healthcare</strong> 的提醒：</p>
</div><h2>Definitive Healthcare Price Performance</h2>
<div class="lb-trans"><h2>Definitive Healthcare 股价表现</h2>
</div><p>Shares of Definitive Healthcare stock traded down $0.02 on Thursday, hitting $0.92. The company's stock had a trading volume of 331,909 shares, compared to its average volume of 354,274. The company has a market capitalization of $97.23 million, a price-to-earnings ratio of -0.74, a price-to-earnings-growth ratio of 84.12 and a beta of 1.34. Definitive Healthcare has a 1 year low of $0.90 and a 1 year high of $4.70. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.64 and a current ratio of 1.64. The firm has a fifty day moving average price of $1.10 and a 200-day moving average price of $1.99.</p>
<div class="lb-trans"><p>周四，Definitive Healthcare 的股票下跌了 0.02 美元，报 0.92 美元。该公司的交易量为 331,909 股，而其平均交易量为 354,274 股。该公司的市值为 9723 万美元，市盈率为-0.74，市盈率增长比率为 84.12，贝塔系数为 1.34。Definitive Healthcare 的一年最低价为 0.90 美元，一年最高价为 4.70 美元。该公司的债务与股本比率为 0.41，速动比率为 1.64，流动比率为 1.64。该公司的 50 日移动平均价格为 1.10 美元，200 日移动平均价格为 1.99 美元。</p>
</div><p>Definitive Healthcare (NASDAQ:DH - Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.03 by $0.03. Definitive Healthcare had a positive return on equity of 2.63% and a negative net margin of 57.52%.The company had revenue of $55.93 million for the quarter, compared to the consensus estimate of $55.02 million. Definitive Healthcare has set its Q2 2026 guidance at 0.030-0.040 EPS and its FY 2026 guidance at 0.160-0.19 EPS. As a group, sell-side analysts anticipate that Definitive Healthcare will post 0.01 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Definitive Healthcare（纳斯达克代码：DH - 获取免费报告）最近在 5 月 7 日发布了季度财报。该公司报告的每股收益（EPS）为 0.06 美元，超出分析师的共识预期 0.03 美元。Definitive Healthcare 的股本回报率为 2.63%，净利润率为-57.52%。该公司季度收入为 5593 万美元，而市场共识预期为 5502 万美元。Definitive Healthcare 将其 2026 年第二季度的指引设定为 0.030-0.040 EPS，2026 财年的指引设定为 0.160-0.19 EPS。整体来看，卖方分析师预计 Definitive Healthcare 在当前财年将发布 0.01 美元的每股收益。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级升级与降级</h2>
</div><p>DH has been the topic of a number of research analyst reports. Canaccord Genuity Group dropped their price target on shares of Definitive Healthcare from $4.00 to $3.00 and set a &#34;hold&#34; rating on the stock in a research note on Friday, February 27th. Barclays reduced their price objective on shares of Definitive Healthcare from $2.75 to $1.00 and set an &#34;underweight&#34; rating for the company in a research report on Monday, March 30th. Wall Street Zen upgraded shares of Definitive Healthcare from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, March 14th. Weiss Ratings reissued a &#34;sell (d-)&#34; rating on shares of Definitive Healthcare in a research note on Wednesday, January 21st. Finally, Zacks Research raised shares of Definitive Healthcare from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday, April 28th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, five have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of &#34;Hold&#34; and an average price target of $3.27.</p>
<div class="lb-trans"><p>DH 成为多家研究分析师报告的主题。Canaccord Genuity Group 在 2 月 27 日的研究报告中将 Definitive Healthcare 的目标股价从 4.00 美元下调至 3.00 美元，并对该股票给予 “持有” 评级。巴克莱在 3 月 30 日的研究报告中将 Definitive Healthcare 的目标股价从 2.75 美元下调至 1.00 美元，并对该公司给予 “减持” 评级。华尔街 Zen 在 3 月 14 日的研究报告中将 Definitive Healthcare 的评级从 “持有” 上调至 “买入”。Weiss Ratings 在 1 月 21 日的研究报告中重新发布了 Definitive Healthcare 的 “卖出（d-）” 评级。最后，Zacks Research 在 4 月 28 日的研究报告中将 Definitive Healthcare 的评级从 “强烈卖出” 上调至 “持有”。一位投资分析师给予该股票 “强烈买入” 评级，一位给予 “买入” 评级，五位给予 “持有” 评级，三位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “持有”，平均目标股价为 3.27 美元。</p>
</div><p><strong>Check Out Our Latest Report on Definitive Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Definitive Healthcare 的最新报告</strong></p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入与流出</h2>
</div><p>Several institutional investors and hedge funds have recently modified their holdings of DH. Goldman Sachs Group Inc. raised its stake in Definitive Healthcare by 564.2% during the first quarter. Goldman Sachs Group Inc. now owns 8,716,725 shares of the company's stock worth $25,191,000 after purchasing an additional 7,404,363 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Definitive Healthcare by 1.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,073,197 shares of the company's stock valued at $8,417,000 after buying an additional 33,612 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in Definitive Healthcare by 11.7% in the third quarter. Arrowstreet Capital Limited Partnership now owns 1,216,007 shares of the company's stock valued at $4,937,000 after acquiring an additional 127,055 shares during the last quarter. Bank of America Corp DE grew its position in Definitive Healthcare by 23.7% in the second quarter. Bank of America Corp DE now owns 769,397 shares of the company's stock worth $3,001,000 after acquiring an additional 147,599 shares during the period. Finally, Inspire Investing LLC increased its stake in Definitive Healthcare by 505.7% during the fourth quarter. Inspire Investing LLC now owns 698,967 shares of the company's stock worth $2,006,000 after acquiring an additional 583,562 shares during the last quarter. Institutional investors and hedge funds own 98.67% of the company's stock.</p>
<div class="lb-trans"><p>几家机构投资者和对冲基金最近调整了对 DH 的持股。高盛集团在第一季度将其在 Definitive Healthcare 的持股增加了 564.2%。高盛集团目前拥有 8716725 股该公司的股票，价值 25191000 美元，此前在此期间又购买了 7404363 股。Dimensional Fund Advisors LP 在第三季度将其在 Definitive Healthcare 的持股增加了 1.6%。Dimensional Fund Advisors LP 目前拥有 2073197 股该公司的股票，价值 8417000 美元，此前在此期间又购买了 33612 股。Arrowstreet Capital Limited Partnership 在第三季度将其在 Definitive Healthcare 的持股增加了 11.7%。Arrowstreet Capital Limited Partnership 目前拥有 1216007 股该公司的股票，价值 4937000 美元，此前在上个季度又收购了 127055 股。美国银行在第二季度将其在 Definitive Healthcare 的持股增加了 23.7%。美国银行目前拥有 769397 股该公司的股票，价值 3001000 美元，此前在此期间又收购了 147599 股。最后，Inspire Investing LLC 在第四季度将其在 Definitive Healthcare 的持股增加了 505.7%。Inspire Investing LLC 目前拥有 698967 股该公司的股票，价值 2006000 美元，此前在上个季度又收购了 583562 股。机构投资者和对冲基金持有该公司 98.67% 的股票。</p>
</div><h2>About Definitive Healthcare</h2>
<div class="lb-trans"><h2>关于 Definitive Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Definitive Healthcare NASDAQ: DH is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.</p>
<div class="lb-trans"><p>Definitive Healthcare（纳斯达克代码：DH）是医疗服务提供者、组织及治疗患者的专业人员的情报和分析的领先提供商。通过其基于云的平台，该公司从多个来源汇总数据，包括索赔、政府登记、商业备案和专有研究，以提供医疗保健领域的统一视图。其解决方案使生命科学公司、医疗服务提供者、支付方和咨询公司能够识别市场机会，优化销售和营销工作，提高运营效率，并支持更好的患者结果。</p>
</div><p>The company's flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.</p>
<div class="lb-trans"><p>该公司的旗舰产品是一个基于订阅的数据平台，提供关于医生、医院、健康系统和后期护理设施的详细资料。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Definitive Healthcare</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Definitive Healthcare 更具投资价值</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Definitive Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Definitive Healthcare 吗？</h2>
</div><p>Before you consider Definitive Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Definitive Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Definitive Healthcare 并不在名单上。</p>
</div><p>While Definitive Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Definitive Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Definitive Healthcare (NASDAQ:DH) Updates Q2 2026 Earnings Guidance

Market Beat

Definitive Healthcare

巴克莱银行

高盛

美国银行

GS Hldg R

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

Definitive Healthcare（纳斯达克股票代码：DH）更新了 2026 年第二季度的收益指引